FBIO
Fortress Biotech, Inc.
+0.03 (+1.22%)2.49USD55.8K成交股數205M市值0.9本益比(近四季)3.0股價營收比+14.0%營收年增(近四季)–下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 0.00 |
| 近 180 天 淨額 | 0.00 |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-22 | 06-24 | Jin David | Chief Financial Officer | A 獲配股票 | 400K | – | – | 1.7M | SEC |
| 2026-04-01 | 04-01 | Jin David | Chief Financial Officer | A 獲配股票 | 3.0K | 2.18 | 6K | 1.3M | SEC |
| 2026-03-18 | 03-20 | WEISS MICHAEL S | Executive Vice Chairman | A 獲配股票 | 475K | – | – | 2.3M | SEC |
| 2026-03-18 | 03-20 | ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CHAIRMAN | A 獲配股票 | 475K | – | – | 4.6M | SEC |
| 2026-01-01 | 01-05 | Hoenlein Malcolm | Director | A 獲配股票 | 27.3K | – | – | 116K | SEC |
| 2026-01-01 | 01-05 | Harvey Jimmie | Director | A 獲配股票 | 27.3K | – | – | 147K | SEC |
| 2026-01-01 | 01-05 | LOBELL J JAY | Director | A 獲配股票 | 27.3K | – | – | 192K | SEC |
| 2026-01-01 | 01-05 | Lorenz Kevin | Director | A 獲配股票 | 27.3K | – | – | 101K | SEC |
| 2026-01-01 | 01-05 | Klein Dov | Director | A 獲配股票 | 27.3K | – | – | 130K | SEC |
| 2025-10-01 | 10-02 | Jin David | Chief Financial Officer | A 獲配股票 | 2.7K | 1.31 | 4K | 1.2M | SEC |
| 2025-04-01 | 04-01 | Jin David | Chief Financial Officer | A 獲配股票 | 5.0K | 1.22 | 6K | 1.2M | SEC |
| 2025-01-01 | 01-03 | Lorenz Kevin | Director | A 獲配股票 | 49.4K | – | – | 73.7K | SEC |
| 2025-01-01 | 01-03 | WEISS MICHAEL S | Executive Vice Chairman | A 獲配股票 | 454K | – | – | 1.8M | SEC |
| 2025-01-01 | 01-03 | Hoenlein Malcolm | Director | A 獲配股票 | 49.4K | – | – | 88.4K | SEC |
| 2025-01-01 | 01-03 | ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CHAIRMAN | A 獲配股票 | 454K | – | – | 4.1M | SEC |
| 2025-01-01 | 01-03 | Klein Dov | Director | A 獲配股票 | 49.4K | – | – | 103K | SEC |
| 2025-01-01 | 01-03 | Harvey Jimmie | Director | A 獲配股票 | 49.4K | – | – | 119K | SEC |
| 2025-01-01 | 01-03 | LOBELL J JAY | Director | A 獲配股票 | 49.4K | – | – | 165K | SEC |
| 2025-01-01 | 01-03 | Lu Lucy | Director | A 獲配股票 | 49.4K | – | – | 61.3K | SEC |
| 2024-12-19 | 12-23 | Jin David | Chief Financial Officer | A 獲配股票 | 1.0M | – | – | 1.2M | SEC |
| 2024-10-01 | 10-01 | Jin David | Chief Financial Officer | A 獲配股票 | 2.6K | 1.23 | 3K | 241K | SEC |
| 2024-09-23 | 09-25 | ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CHAIRMAN | P 公開市場買進 | 763K | 1.84 | 1.4M | 3.7M | SEC |
| 2024-07-11 | 07-15 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | P 公開市場買進 | 5.0K | 7.48 | 37K | 128K | SEC |
| 2024-07-10 | 07-12 | Jin David | Chief Financial Officer | P 公開市場買進 | 500 | 7.50 | 4K | 500 | SEC |
| 2024-07-09 | 07-11 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | P 公開市場買進 | 5.0K | 7.39 | 37K | 123K | SEC |
| 2024-07-08 | 07-10 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | P 公開市場買進 | 5.0K | 7.35 | 37K | 118K | SEC |
| 2024-06-28 | 07-01 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | P 公開市場買進 | 20.0K | 1.64 | 33K | 2.9M | SEC |
| 2024-05-20 | 05-20 | Klein Dov | Director | S 公開市場賣出 | 10.0K | 1.89 | 19K | 53.4K | SEC |
| 2024-05-16 | 05-20 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | P 公開市場買進 | 10.0K | 1.76 | 18K | 2.9M | SEC |
| 2024-04-01 | 04-02 | Jin David | Chief Financial Officer | A 獲配股票 | 2.4K | 1.70 | 4K | 238K | SEC |
| 2024-01-05 | 01-09 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | P 公開市場買進 | 50.0K | 2.38 | 119K | 2.9M | SEC |
| 2024-01-01 | 01-03 | Rowinsky Eric K | Director | A 獲配股票 | 6.7K | – | – | 68.8K | SEC |
| 2024-01-01 | 01-03 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | A 獲配股票 | 216K | – | – | 2.8M | SEC |
| 2024-01-01 | 01-03 | Lu Lucy | Director | A 獲配股票 | 3.3K | – | – | 11.9K | SEC |
| 2024-01-01 | 01-03 | Lorenz Kevin | Director | A 獲配股票 | 3.3K | – | – | 24.3K | SEC |
| 2024-01-01 | 01-03 | Hoenlein Malcolm | Director | A 獲配股票 | 3.3K | – | – | 39.0K | SEC |
| 2024-01-01 | 01-03 | LOBELL J JAY | Director | A 獲配股票 | 6.7K | – | – | 116K | SEC |
| 2024-01-01 | 01-03 | Klein Dov | Director | A 獲配股票 | 6.7K | – | – | 63.4K | SEC |
| 2024-01-01 | 01-03 | WEISS MICHAEL S | See Remarks | A 獲配股票 | 216K | – | – | 1.3M | SEC |
| 2024-01-01 | 01-03 | Harvey Jimmie | Director | A 獲配股票 | 6.7K | – | – | 70.0K | SEC |
| 2023-12-20 | 12-22 | Jin David | Chief Financial Officer | A 獲配股票 | 140K | – | – | 236K | SEC |
| 2023-11-14 | 11-16 | WEISS MICHAEL S | See Remarks | P 公開市場買進 | 147K | 1.70 | 250K | 1.1M | SEC |
| 2023-11-14 | 11-16 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | P 公開市場買進 | 1.6M | 1.70 | 2.7M | 2.6M | SEC |
| 2023-09-26 | 09-27 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | P 公開市場買進 | 100K | 0.28 | 28K | 15.4M | SEC |
| 2023-08-18 | 08-21 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | P 公開市場買進 | 10.0K | 9.34 | 93K | 113K | SEC |
| 2023-08-17 | 08-21 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | P 公開市場買進 | 10.0K | 11.75 | 118K | 103K | SEC |
| 2023-02-10 | 02-14 | Lu Lucy | Director | P 公開市場買進 | 12.0K | 0.84 | 10K | 133K | SEC |
| 2023-02-10 | 02-14 | LOBELL J JAY | Director | P 公開市場買進 | 299K | 0.84 | 251K | 1.6M | SEC |
| 2023-02-10 | 02-14 | WEISS MICHAEL S | See Remarks | P 公開市場買進 | 1.2M | 0.84 | 1.0M | 14.8M | SEC |
| 2023-02-10 | 02-14 | Jin David | Chief Financial Officer | P 公開市場買進 | 35.9K | 0.84 | 30K | 1.4M | SEC |
| 2023-02-10 | 02-14 | Rowinsky Eric K | Director | P 公開市場買進 | 12.0K | 0.84 | 10K | 932K | SEC |
| 2023-02-10 | 02-14 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | P 公開市場買進 | 2.4M | 0.84 | 2.0M | 15.3M | SEC |
| 2023-01-01 | 01-04 | LOBELL J JAY | Director | A 獲配股票 | 100K | – | – | 1.3M | SEC |
| 2023-01-01 | 01-04 | Lu Lucy | Director | A 獲配股票 | 50.0K | – | – | 121K | SEC |
| 2023-01-01 | 01-04 | Hoenlein Malcolm | Director | A 獲配股票 | 50.0K | – | – | 536K | SEC |
| 2023-01-01 | 01-04 | WEISS MICHAEL S | See Remarks | A 獲配股票 | 1.2M | – | – | 13.6M | SEC |
| 2023-01-01 | 01-04 | Rowinsky Eric K | Director | A 獲配股票 | 100K | – | – | 920K | SEC |
| 2023-01-01 | 01-04 | Lorenz Kevin | Director | A 獲配股票 | 50.0K | – | – | 315K | SEC |
| 2023-01-01 | 01-04 | Harvey Jimmie | Director | A 獲配股票 | 100K | – | – | 950K | SEC |
| 2023-01-01 | 01-04 | Klein Dov | Director | A 獲配股票 | 100K | – | – | 851K | SEC |
| 2023-01-01 | 01-04 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | A 獲配股票 | 1.2M | – | – | 13.0M | SEC |
| 2022-12-16 | 12-19 | Lu Lucy | Director | A 獲配股票 | 30.0K | – | – | 71.4K | SEC |
| 2022-12-01 | 12-05 | ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CHAIRMAN | P 公開市場買進 | 100K | 0.68 | 68K | 11.7M | SEC |
| 2022-11-30 | 12-02 | Jin David | Chief Financial Officer | P 公開市場買進 | 5.0K | 0.56 | 3K | 1.4M | SEC |
| 2022-11-30 | 12-02 | ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CHAIRMAN | P 公開市場買進 | 5.0K | 0.56 | 3K | 11.6M | SEC |
| 2022-10-26 | 10-28 | Jin David | Chief Financial Officer | A 獲配股票 | 1.4M | – | – | 1.4M | SEC |
| 2022-10-21 | 10-24 | ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CHAIRMAN | P 公開市場買進 | 100K | 0.70 | 70K | 11.6M | SEC |
| 2022-06-01 | 01-04 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | A 獲配股票 | 4.3K | 0.73 | 3K | 11.7M | SEC |
| 2022-01-01 | 04-29 | Hoenlein Malcolm | Director | A 獲配股票 | 50.0K | – | – | 486K | SEC |
| 2022-01-01 | 04-29 | WEISS MICHAEL S | See Remarks | A 獲配股票 | 1.1M | – | – | 12.3M | SEC |
| 2022-01-01 | 04-29 | ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CHAIRMAN | A 獲配股票 | 1.1M | – | – | 11.5M | SEC |
| 2022-01-01 | 04-29 | Klein Dov | Director | A 獲配股票 | 100K | – | – | 751K | SEC |
| 2022-01-01 | 04-29 | Lorenz Kevin | Director | A 獲配股票 | 50.0K | – | – | 265K | SEC |
| 2022-01-01 | 04-29 | Harvey Jimmie | Director | A 獲配股票 | 100K | – | – | 850K | SEC |
| 2022-01-01 | 04-29 | LOBELL J JAY | Director | A 獲配股票 | 100K | – | – | 1.2M | SEC |
| 2022-01-01 | 04-29 | Rowinsky Eric K | Director | A 獲配股票 | 100K | – | – | 820K | SEC |
| 2021-12-28 | 04-29 | Klein Dov | Director | S 公開市場賣出 | 5.0K | 2.45 | 12K | 651K | SEC |
| 2021-12-01 | 04-29 | ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CHAIRMAN | A 獲配股票 | 1.3K | 2.42 | 3K | 10.4M | SEC |
| 2021-11-16 | 04-29 | Hoenlein Malcolm | Director | J 其他 | 230 | – | – | 436K | SEC |
| 2021-11-16 | 04-29 | ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CHAIRMAN | J 其他 | 4.6K | – | – | 10.4M | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 1.0M | 3.2M | 新進 | 新進 |
| Opaleye Management Inc. | 890K | 2.7M | 新進 | 新進 |
| MACKENZIE FINANCIAL CORP | 556K | 1.7M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 301K | 920K | 新進 | 新進 |
| BlackRock, Inc. | 225K | 688K | 新進 | 新進 |
| Two Sigma TWO SIGMA INVESTMENTS, LP | 214K | 654K | 新進 | 新進 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 177K | 543K | 新進 | 新進 |
| VANGUARD FIDUCIARY TRUST CO | 166K | 509K | 新進 | 新進 |
| HB Wealth Management, LLC | 117K | 357K | 新進 | 新進 |
| Kestra Advisory Services, LLC | 116K | 356K | 新進 | 新進 |
| STATE STREET CORP | 102K | 311K | 新進 | 新進 |
| GOLDMAN SACHS GROUP INC | 96.4K | 295K | 新進 | 新進 |
| Integrated Wealth Concepts LLC | 90.4K | 277K | 新進 | 新進 |
| 文藝復興 RENAISSANCE TECHNOLOGIES LLC | 86.4K | 264K | 新進 | 新進 |
| 城堡 CITADEL ADVISORS LLC | 77.1K | 236K | 新進 | 新進 |
| Integrated Quantitative Investments LLC | 68.7K | 210K | 新進 | 新進 |
| PANAGORA ASSET MANAGEMENT INC | 66.0K | 202K | 新進 | 新進 |
| NORTHERN TRUST CORP | 63.6K | 195K | 新進 | 新進 |
| 180 WEALTH ADVISORS, LLC | 61.6K | 188K | 新進 | 新進 |
| UBS Group AG | 52.3K | 160K | 新進 | 新進 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 47.0K | 144K | 新進 | 新進 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 41.5K | 127K | 新進 | 新進 |
| PFG Investments, LLC | 36.5K | 112K | 新進 | 新進 |
| CHOREO, LLC | 36.3K | 111K | 新進 | 新進 |
| JANE STREET GROUP, LLC | 25.4K | 78K | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 55 +3 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 55 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 5.8M · 7.1% |
| 合計季末市值 | 15.1M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 5.4M |
|---|---|
| 與上期比 | -2.4% |
| 佔流通股數 | 6.60% |
| 日均成交量 | 455K |
| 回補天數 | 12.0 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 5.4M | -2.4% | 6.60% | 455K | 12.0 |
| 2026-08-14 | 5.6M | -3.6% | 6.76% | 974K | 5.7 |
| 2026-07-31 | 5.8M | +7.5% | 7.01% | 481K | 12.0 |
| 2026-07-15 | 5.4M | +1.4% | 6.52% | 648K | 8.3 |
| 2026-06-30 | 5.3M | +3.2% | 6.43% | 627K | 8.5 |
| 2026-06-15 | 5.1M | +1.0% | 6.24% | 467K | 11.0 |
| 2026-05-29 | 5.1M | +4.3% | 6.17% | 450K | 11.3 |
| 2026-05-15 | 4.9M | +5.0% | 5.92% | 336K | 14.5 |
| 2026-04-30 | 4.6M | +2.3% | 5.64% | 261K | 17.8 |
| 2026-04-15 | 4.5M | +4.2% | 5.51% | 540K | 8.4 |
| 2026-03-31 | 4.4M | +2.0% | 5.29% | 477K | 9.2 |
| 2026-03-13 | 4.3M | -4.6% | 5.19% | 445K | 9.6 |
| 2026-02-27 | 4.5M | +4.0% | 5.44% | 1.3M | 3.4 |
| 2026-02-13 | 4.3M | -6.0% | 5.23% | 559K | 7.7 |
| 2026-01-30 | 4.6M | +2.0% | 5.56% | 566K | 8.1 |
| 2026-01-15 | 4.5M | +11.0% | 5.45% | 1.9M | 2.4 |
| 2025-12-31 | 4.0M | +11.6% | 4.90% | 568K | 7.1 |
| 2025-12-15 | 3.6M | -2.2% | 4.40% | 496K | 7.3 |
| 2025-11-28 | 3.7M | -6.8% | 4.49% | 302K | 12.3 |
| 2025-11-14 | 4.0M | +13.4% | 4.82% | 360K | 11.0 |
| 2025-10-31 | 3.5M | +3.8% | 4.25% | 437K | 8.0 |
| 2025-10-15 | 3.4M | -9.9% | 4.10% | 1.5M | 2.2 |
| 2025-09-30 | 3.8M | -1.1% | 4.55% | 1.3M | 2.9 |
| 2025-09-15 | 3.8M | +25.2% | 4.60% | 1.9M | 2.0 |
| 2025-08-29 | 3.0M | +8.5% | 3.67% | 629K | 4.8 |
| 2025-08-15 | 2.8M | -6.5% | 3.38% | 235K | 11.9 |